# New Animal Drugs; Ractopamine
> **Food and Drug Administration** · Final rule. · Published 2007-11-06 · Effective 2007-11-06 · 72 FR 62570
## Document
- **Document number:** E7-21816
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 72 FR 62570
- **CFR reference:** 21 CFR 558
- **Publication date:** 2007-11-06
- **Effective date:** 2007-11-06
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health. The supplemental NADA provides for an increased level of monensin in three-way combination Type C medicated feeds containing ractopamine, monensin, and tylosin for cattle fed in confinement for slaughter and a revision to bacterial pathogen nomenclature.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2007/11/06/E7-21816/new-animal-drugs-ractopamine)
---
*AI Analytics · CC0 1.0*